Long-term classification stability and treatment patterns of inflammatory bowel disease unclassified: a longitudinal observational study
Mario Andrea Latorre, Michael Rennie, Konstantina Rosiou, Marco Vincenzo Lenti, Christian Philipp Selinger · 2026
Read Long-term classification stability and treatment patterns of inflammatory bowel disease unclassified: a longitudinal observational study by Mario Andrea Latorre, Michael Rennie, Konstantina Rosiou, Marco Vincenzo Lenti, Christian Philipp Selinger (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13264831.txt.
Description
Mario Andrea Latorre and co-authors wrote a 2026 study on inflammatory bowel disease unclassified, the label used when gut inflammation cannot be sorted as ulcerative colitis or Crohn's disease. Doctors did not know how often that label sticks over time. Using records from a large Leeds hospital unit, the team followed such patients to 2025.
The group held 153 patients, with a mean age of 46.6 and mean illness length of 13.1 years. Their drug patterns sat between the two named diseases: more use of one gut drug and more biologic use than colitis, but less than Crohn's. Steroid use and health care use ran higher than in both named diseases. At the end, 88.2 percent still carried the unclassified label. The authors call it a lasting form in its own right.
Catalog record
| CREATOR | Mario Andrea Latorre, Michael Rennie, Konstantina Rosiou, Marco Vincenzo Lenti, Christian Philipp Selinger |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28932 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |